160 related articles for article (PubMed ID: 17489033)
1. Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies.
Stanghellini V; Armstrong D; Mönnikes H; Berghöfer P; Gatz G; Bardhan KD
Digestion; 2007; 75 Suppl 1():55-61. PubMed ID: 17489033
[TBL] [Abstract][Full Text] [Related]
2. Determination of ReQuest-based symptom thresholds to define symptom relief in GERD clinical studies.
Stanghellini V; Armstrong D; Mönnikes H; Berghöfer P; Gatz G; Bardhan KD
Digestion; 2005; 71(3):145-51. PubMed ID: 15870502
[TBL] [Abstract][Full Text] [Related]
3. Look--but also listen! ReQuest: an essay on a new validated scale to assess the outcome of GERD treatment.
Bardhan KD; Berghöfer P
Digestion; 2007; 75 Suppl 1():87-100. PubMed ID: 17489037
[TBL] [Abstract][Full Text] [Related]
4. ReQuest-- the challenge of quantifying both esophageal and extra-esophageal manifestations of GERD.
Stanghellini V
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():27-30. PubMed ID: 15588792
[TBL] [Abstract][Full Text] [Related]
5. ReQuest: a new questionnaire for the simultaneous evaluation of symptoms and well-being in patients with gastro-oesophageal reflux.
Ducrotté P; Zerbib F
Digestion; 2007; 75 Suppl 1():79-86. PubMed ID: 17489036
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.
Mönnikes H; Bardhan KD; Stanghellini V; Berghöfer P; Bethke TD; Armstrong D
Digestion; 2007; 75 Suppl 1():41-7. PubMed ID: 17489031
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community.
Wiklund I; Carlsson J; Vakil N
Am J Gastroenterol; 2006 Jan; 101(1):18-28. PubMed ID: 16405529
[TBL] [Abstract][Full Text] [Related]
8. The construction of a new evaluative GERD questionnaire--methods and state of the art.
Armstrong D; Mönnikes H; Bardhan KD; Stanghellini V
Digestion; 2007; 75 Suppl 1():17-24. PubMed ID: 17489028
[TBL] [Abstract][Full Text] [Related]
9. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
Digestion; 2007; 75 Suppl 1():62-8. PubMed ID: 17489034
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD.
Mönnikes H; Bardhan KD; Stanghellini V; Berghöfer P; Bethke TD; Armstrong D
Digestion; 2004; 69(4):238-44. PubMed ID: 15256830
[TBL] [Abstract][Full Text] [Related]
11. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?
Gold BD
Am J Gastroenterol; 2006 Mar; 101(3):641-4. PubMed ID: 16542297
[TBL] [Abstract][Full Text] [Related]
12. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment.
Fass R
J Clin Gastroenterol; 2007; 41(5):437-44. PubMed ID: 17450022
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest.
Bardhan KD; Stanghellini V; Armstrong D; Berghöfer P; Gatz G; Mönnikes H
Digestion; 2007; 75 Suppl 1():32-40. PubMed ID: 17489030
[TBL] [Abstract][Full Text] [Related]
14. Validation of a brief symptom questionnaire (ReQuest in Practice) for patients with gastro-oesophageal reflux disease.
Rubin G; Uebel P; Brimo-Hayek A; Hey KH; Doerfler H; Heading RC
Aliment Pharmacol Ther; 2008 May; 27(9):846-51. PubMed ID: 18266995
[TBL] [Abstract][Full Text] [Related]
15. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD.
Brozek JL; Guyatt GH; Heels-Ansdell D; Degl'Innocenti A; Armstrong D; Fallone CA; Wiklund I; van Zanten SV; Chiba N; Barkun AN; Akl EA; Schünemann HJ
J Clin Epidemiol; 2009 Jan; 62(1):102-10. PubMed ID: 18619804
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest.
Bardhan KD; Stanghellini V; Armstrong D; Berghöfer P; Gatz G; Mönnikes H
Digestion; 2004; 69(4):229-37. PubMed ID: 15256829
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal women.
Infantino M
J Am Acad Nurse Pract; 2008 May; 20(5):266-72. PubMed ID: 18460167
[TBL] [Abstract][Full Text] [Related]
18. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.
Bardhan KD; Stanghellini V; Armstrong D; Berghöfer P; Gatz G; Mönnikes H
Aliment Pharmacol Ther; 2004 Oct; 20(8):891-8. PubMed ID: 15479361
[TBL] [Abstract][Full Text] [Related]
19. Review article: Gastro-oesophageal reflux disease--application of the concept of complete remission.
Oudkerk Pool M
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():13-6. PubMed ID: 18081644
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study.
Eslick GD; Talley NJ
J Clin Gastroenterol; 2009 Feb; 43(2):111-7. PubMed ID: 18838922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
